Pure Global
NCT06143449

Taiwan Diabetes Registry

Taiwan Diabetes Registry (TDR)
The Diabetes Association of the Republic of China (Taiwan)·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Diabetes Mellitus
Drug/Device/Intervention
Observational study - registry
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
The Diabetes Association of the Republic of China (Taiwan)
Location
Taipei, Taiwan
Timeline & enrollment
Phase
N/A
Start date
Oct 01, 2015
End date
Dec 31, 2030
Enrollment
24000 participants
Primary outcome

Provide data on patient characteristics,Provide data on disease management.

Summary

To Investigate the Risk Factors, Life Style and Treatments of the Microvascular
 Disease，Macrovascular Disease and Neuropathy in Patients With Diabetes.

ICD-10 classifications
Diabetes mellitusUnspecified diabetes mellitusOther specified diabetes mellitusUnspecified diabetes mellitus without complicationsUnspecified diabetes mellitus with unspecified complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06143449
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06143449 through Pure Global AI's free database. This phase not specified trial is sponsored by The Diabetes Association of the Republic of China (Taiwan) and is currently Recruiting. The study focuses on Diabetes Mellitus. Target enrollment is 24000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.